Rescuing brain insulin signaling activation might promote neuroprotective effects by reducing AD neuropathological hallmarks in the brain, by improving synaptic plasticity mechanisms, and by stimulating cell energy metabolism, which are all processes known to be impaired in DS [4,57]. This evidence concerns the gene INS and Dravet syndrome.